Transition Care in IBD

10:20 - 10:50 am

Eric Benchimol, MD, PhD, FRCP(C) 

Professor, Department of Paediatrics, University of Toronto
Division of Gastroenterology, Hepatology and Nutrition
The Hospital for Sick Children 

Dr. Eric Benchimol graduated from Western University’s MD program and completed his pediatrics residency at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa before joining the SickKids for his GI fellowship. During that time, he completed a PhD in Clinical Epidemiology at University of Toronto and ICES, graduating in 2010. He spent 10 years as a pediatric gastroenterologist and clinician-scientist at CHEO, specializing in inflammatory bowel disease. He was also Director of the Health Information Technology Program at the CHEO Research Institute and led the development of the CHEO Research Data Warehouse using Epic clinical data. He rejoined SickKids in September 2020 as a clinician-scientist at the SickKids IBD Centre.

Dr. Benchimol chairs the Canadian Gastro-Intestinal Epidemiology Consortium (, which conducts epidemiology, pharmacoepidemiology, outcomes, and health services research using the health administrative data from multiple provinces. Dr. Benchimol is also Chair of the Scientific and Medical Advisory Council of Crohn’s and Colitis Canada.

Presentation Overview:

Underpinned by high-quality scientific evidence, the endoscopic management of colonic neoplasia has undergone a rapid sequence of changes in the last 5 -10 years, which has resulted in substantial improvements in cost-efficacy, safety, and clinical effectiveness. I will talk about progress in conventional polypectomy including the science of cold snare polypectomy. I will also discuss the evidence and direction of travel for complex tissue resection including EMR, techniques for minimizing adverse events and recurrence, and the role of ESD.


  1. Understand the challenges faced by AYAs with IBD transitioning from pediatric to adult care.
  2. Review the evidence of interventions which may improve transition.
  3. Discuss upcoming Canadian clinical guidelines on transition from pediatric to adult IBD care.